rivaroxaban oral suspension — Medica
Venous thromboembolism prophylaxis in acutely ill medical patients
Initial criteria
- Patient is age ≥ 18 years
- If rivaroxaban oral suspension is being requested, patient is unable to have Xarelto tablets appropriately administered
Approval duration
60 days